Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer

por Halm, U, Schumann, T, Schiefke, I, Witzigmann, H, Mössner, J, Keim, V
Publicado 2000

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver

por Tannapfel, A, Engeland, K, Weinans, L, Katalinic, A, Hauss, J, Mössner, J, Wittekind, Ch
Publicado 1999

Heparanase is a prognostic indicator for postoperative survival in pancreatic carcinoma

por Rohloff, J, Zinke, J, Schoppmeyer, K, Tannapfel, A, Witzigmann, H, Mössner, J, Wittekind, C, Caca, K
Publicado 2002

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

por Rohloff, J, Zinke, J, Schoppmeyer, K, Tannapfel, A, Witzigmann, H, Mössner, J, Wittekind, C, Caca, K
Publicado 2002

Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model

por Hermes, M, Schormann, W, Brulport, M, Uhlemann, K, Lupatsch, F, Horn, L C, Schumann, A, Allgaier, C, Weishaupt, M, Engeland, K, Müller, G A, Mössner, J, Bauer, A, Schiffer, I B, Gebhard, S, Schmidt, M, Lausch, E, Prawitt, D, Wilhelm, C, Hengstler, J G
Publicado 2008